Long non-coding RNAs: a valuable biomarker for metabolic syndrome

Long non-coding RNAs (lncRNAs) have become important regulators of gene expression because they affect a wide range of biological processes, such as cell growth, death, differentiation, and aging. More and more evidence suggests that lncRNAs play a role in maintaining metabolic homeostasis. When certain lncRNAs are out of balance, metabolic disorders like diabetes, obesity, and heart disease get worse. In this review, we talk about what we know about how lncRNAs control metabolism, with a focus on diseases caused by long-term inflammation and the characteristics of the metabolic syndrome. We looked at lncRNAs and their molecular targets in the pathogenesis of signaling pathways. We also talked about how lncRNAs are becoming more and more interesting as diagnostic and therapeutic targets for improving metabolic homeostasis.

Automated summary

Long non-coding RNAs (lncRNAs) have emerged as important regulators of gene expression, influencing various biological processes such as cell growth, death, differentiation, and aging. Evidence suggests that imbalances in lncRNAs play a role in metabolic disorders including diabetes, obesity, and heart disease. This review focuses on the understanding of how lncRNAs control metabolism, particularly in diseases caused by chronic inflammation and metabolic syndrome. The potential of lncRNAs as diagnostic and therapeutic targets for improving metabolic homeostasis is also discussed.